Old Web
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies
2011
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
37
References
34
Citations
NaN
KQI